Prospective––retrospective biomarker analysis for regulatory consideration: white paper from the industry pharmacogenomics working group

Author： Patterson Scott D   Cohen Nadine   Karnoub Maha   Truter Sharada Louis   Emison Eileen   Khambata-Ford Shirin   Spear Brian   Ibia Ekopimo   Sproule Rizwana   Barnes Diane   Bhathena Anahita   Bristow Michael R   Russell Chris   Wang Dai   Warner Amelia   Westelinck Agnes   Brian William   Snapir Amir   Franc Monique A   Wong Peggy   Shaw Peter M  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.12, Iss.7, 2011-07, pp. : 939-951

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Methods for analysis in pharmacogenomics: lessons from the Pharmacogenetics Research Network Analysis Group

By Srinivasan Balaji S   Chen Jinbo   Cheng Cheng   Conti David   Duan Shiwei   Fridley Brooke L   Gu Xiangjun   Haines Jonathan L   Jorgenson Eric   Kraja Aldi   Lasky-Su Jessica   Li Lang   Rodin Andrei   Wang Dai   Province Mike   Ritchie Marylyn D  

Pharmacogenomics, Vol. 10, Iss. 2, 2009-02 ,pp. : 243-251

Future Medicine

Access to resources Recommend Favorite

Discussion of the "White Paper of the PhRMA PISC Working Group on Adaptive Dose-Ranging Designs"

By Leonov Sergei  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 1013-1014

Taylor & Francis Ltd

Access to resources Recommend Favorite

Discussion of the "White Paper of the PhRMA Working Group on Adaptive Dose-Ranging Designs"

By Grieve A. P.  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 997-1004

Taylor & Francis Ltd

Access to resources Recommend Favorite

Discussion of "The White Paper of the PhRMA Working Group on Adaptive Dose-Ranging Designs"

By Hemmings Robert  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 1021-1027

Taylor & Francis Ltd

Access to resources Recommend Favorite

Discussion of the "White Paper of the PhRMA Working Group on Adaptive Dose-Ranging Designs"

By Wang Sue-Jane  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 1015-1020

Taylor & Francis Ltd

Access to resources Recommend Favorite